| P2093 | author name string | Ajit Varki | |
| | Nancy Hurtado-Ziola | |
| | Stephen M Hedrick | |
| | Lance L Stein | |
| | Paula C Soto | |
| P2860 | cites work | Simian Immunodeficiency Virus Infection of Chimpanzees | Q22065437 |
| | Comparing the human and chimpanzee genomes: Searching for needles in a haystack | Q22065747 |
| | Initial sequence of the chimpanzee genome and comparison with the human genome | Q22122468 |
| | Chimpanzee reservoirs of pandemic and nonpandemic HIV-1 | Q22242279 |
| | Nef-Mediated Suppression of T Cell Activation Was Lost in a Lentiviral Lineage that Gave Rise to HIV-1 | Q22252321 |
| | Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8 | Q24310398 |
| | Anti-Siglec-F antibody reduces allergen-induced eosinophilic inflammation and airway remodeling | Q24645925 |
| | Defining the in vivo function of Siglec-F, a CD33-related Siglec expressed on mouse eosinophils | Q24678441 |
| | Signaling signatures and functional properties of anti-human CD28 superagonistic antibodies | Q27301837 |
| | Analysis of hepatitis C virus-inoculated chimpanzees reveals unexpected clinical profiles. | Q27469551 |
| | Foxp3+CD4+CD25+ T cells control virus-specific memory T cells in chimpanzees that recovered from hepatitis C | Q27480306 |
| | Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif | Q28187133 |
| | Siglecs--the major subfamily of I-type lectins | Q28261393 |
| | Discovery of Siglec-14, a novel sialic acid receptor undergoing concerted evolution with Siglec-5 in primates | Q28266246 |
| | Negative regulation of T cell receptor signaling by Siglec-7 (p70/AIRM) and Siglec-9 | Q28275490 |
| | Siglecs and their roles in the immune system | Q28294469 |
| | Eosinophil-selective binding and proapoptotic effect in vitro of a synthetic Siglec-8 ligand, polymeric 6'-sulfated sialyl Lewis x. | Q38353914 |
| | Characterization of the structural determinants required for the high affinity interaction of asparagine-linked oligosaccharides with immobilized Phaseolus vulgaris leukoagglutinating and erythroagglutinating lectins. | Q38355186 |
| | Siglec-E is up-regulated and phosphorylated following lipopolysaccharide stimulation in order to limit TLR-driven cytokine production. | Q39771500 |
| | Deletion polymorphism of SIGLEC14 and its functional implications | Q39860510 |
| | Siglec-G is a B1 cell-inhibitory receptor that controls expansion and calcium signaling of the B1 cell population | Q40119175 |
| | Siglec-H is an IPC-specific receptor that modulates type I IFN secretion through DAP12. | Q40350295 |
| | A Toll-like receptor 7 single nucleotide polymorphism protects from advanced inflammation and fibrosis in male patients with chronic HCV-infection | Q41604084 |
| | Immune system: not so superior | Q42853710 |
| | Divergent TLR7 and TLR9 signaling and type I interferon production distinguish pathogenic and nonpathogenic AIDS virus infections | Q43814365 |
| | The chimpanzee model: contributions and considerations for studies of hepatitis B virus | Q45694762 |
| | Comparative features of hepatitis C virus infection in humans and chimpanzees | Q45761050 |
| | Lack of chronic immune activation in HIV-infected chimpanzees correlates with the resistance of T cells to Fas/Apo-1 (CD95)-induced apoptosis and preservation of a T helper 1 phenotype | Q46812465 |
| | Triggering TLR7 in mice induces immune activation and lymphoid system disruption, resembling HIV-mediated pathology. | Q52589485 |
| | Immunophenotyping of peripheral blood, ranges of serum chemistries and clinical hematology values of healthy chimpanzees (Pan troglodytes). | Q52843962 |
| | Divergence of human and nonhuman primate lymphocyte responses to bacterial superantigens. | Q52846081 |
| | Transmission of HTLV-III Infection from Human Plasma to Chimpanzees: An Animal Model for AIDS | Q52849903 |
| | Efficient expansion of regulatory T cells in vitro and in vivo with a CD28 superagonist | Q56903962 |
| | TGN1412—a regulator's perspective | Q63952507 |
| | Cross-linking of CD4 molecules upregulates Fas antigen expression in lymphocytes by inducing interferon-gamma and tumor necrosis factor-alpha secretion | Q71648338 |
| | Superantigen-mediated deletion of specific T cell receptor V beta subsets in the SCID-hu Thy/Liv mouse is induced by staphylococcal enterotoxin B, but not HIV-1 | Q71968265 |
| | Analysis of the V beta specificity of superantigen activation with a rapid and sensitive method using RT PCR and an automatic DNA analyser | Q72527048 |
| | CD28-mediated induction of proliferation in resting T cells in vitro and in vivo without engagement of the T cell receptor: evidence for functionally distinct forms of CD28 | Q73043300 |
| | Triggering of T cell proliferation through CD28 induces GATA-3 and promotes T helper type 2 differentiation in vitro and in vivo | Q73281771 |
| | Autonomous induction of proliferation, JNK and NF-alphaB activation in primary resting T cells by mobilized CD28 | Q73603867 |
| | Treatment and prevention of experimental autoimmune neuritis with superagonistic CD28-specific monoclonal antibodies | Q73676653 |
| | T-cell costimulation--biology, therapeutic potential, and challenges | Q80111065 |
| | Measurement of proliferative responses of cultured lymphocytes | Q81831780 |
| | Improved in vitro methods to predict the in vivo toxicity in man of therapeutic monoclonal antibodies including TGN1412 | Q84862653 |
| | Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA | Q28513215 |
| | Evolution in health and medicine Sackler colloquium: Evolution of the human lifespan and diseases of aging: roles of infection, inflammation, and nutrition | Q28752234 |
| | Mitochondrial sequences show diverse evolutionary histories of African hominoids | Q28776507 |
| | Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412 | Q29622893 |
| | Characterization of siglec-5, a novel glycoprotein expressed on myeloid cells related to CD33. | Q32025719 |
| | Rapid regulatory T-cell response prevents cytokine storm in CD28 superagonist treated mice | Q33413095 |
| | Retrovirus restriction by TRIM5alpha variants from Old World and New World primates | Q33707501 |
| | A chimpanzee genome project is a biomedical imperative | Q34013588 |
| | Redefining chronic viral infection | Q34018497 |
| | The ITAM-bearing transmembrane adaptor DAP12 in lymphoid and myeloid cell function | Q34103308 |
| | Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation | Q34178136 |
| | Studies of hepatitis C virus in chimpanzees and their importance for vaccine development. | Q34339587 |
| | Siglec-5 (CD170) can mediate inhibitory signaling in the absence of immunoreceptor tyrosine-based inhibitory motif phosphorylation. | Q34403249 |
| | Varicella in Chimpanzees | Q34409960 |
| | Pathogenetic effector function of CD4-positive T helper 1 cells in hepatitis B virus transgenic mice | Q34435520 |
| | Superagonistic anti-CD28 antibodies: potent activators of regulatory T cells for the therapy of autoimmune diseases | Q34461477 |
| | Origins of HIV and the evolution of resistance to AIDS. | Q34551881 |
| | Selection and characterization of T-cell variants lacking molecules involved in T-cell activation (T3 T-cell receptor, T44, and T11): analysis of the functional relationship among different pathways of activation. | Q34606067 |
| | Loss of Siglec expression on T lymphocytes during human evolution | Q34650845 |
| | CD28 superagonists: what makes the difference in humans? | Q34656318 |
| | T cell anergy | Q35019694 |
| | A case report of hepatocellular carcinoma and focal nodular hyperplasia with a myelolipoma in two chimpanzees and a review of spontaneous hepatobiliary tumors in non-human primates | Q35734094 |
| | Development of AIDS in a chimpanzee infected with human immunodeficiency virus type 1 | Q35884252 |
| | The acquired immune system: a vantage from beneath | Q35946300 |
| | Siglecs in innate immunity | Q36162931 |
| | CD28 superagonists: mode of action and therapeutic potential | Q36212965 |
| | The quality of chimpanzee T-cell activation and simian immunodeficiency virus/human immunodeficiency virus susceptibility achieved via antibody-mediated T-cell receptor/CD3 stimulation is a function of the anti-CD3 antibody isotype | Q36933992 |
| | The B7 family and cancer therapy: costimulation and coinhibition | Q36944386 |
| | Immunobiology and pathogenesis of viral hepatitis | Q37014739 |
| | Molecular mimicry of host sialylated glycans allows a bacterial pathogen to engage neutrophil Siglec-9 and dampen the innate immune response | Q37151185 |
| | Group B Streptococcus suppression of phagocyte functions by protein-mediated engagement of human Siglec-5. | Q37292766 |
| | Siglec-8 on human eosinophils and mast cells, and Siglec-F on murine eosinophils, are functionally related inhibitory receptors | Q37343465 |
| | Non-human primate surrogate model of hepatitis C virus infection. | Q37374994 |
| | CD24 and Siglec-10 selectively repress tissue damage-induced immune responses. | Q37396101 |
| | Chimpanzees in hepatitis C virus research: 1998-2007. | Q37629878 |
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | lymphocyte | Q715347 |
| | chimpanzee | Q4126704 |
| P304 | page(s) | 4185-4195 | |
| P577 | publication date | 2010-03-15 | |
| P1433 | published in | Journal of Immunology | Q3521441 |
| P1476 | title | Relative over-reactivity of human versus chimpanzee lymphocytes: implications for the human diseases associated with immune activation | |
| P478 | volume | 184 | |